Clinical Trial Update: Effect of Rosuvastatin on Endothelial Function [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating rosuvastatin's impact on endothelial function in participants with HIV infection and cardiovascular disease. The study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University of Hawaii | Conditions: HIV Infections, Cardiovascular Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2015-01-29